Table 1.
Characteristic | Patients (n = 260) |
---|---|
Mean ± SD age, years |
48.9 ± 20 |
Males, n (%) |
149 (57.3) |
Comorbidities, n (%) |
|
Diabetes mellitus |
12 (4.6) |
Obesity |
12 (4.6) |
Lifestyle factors, n (%) |
|
Smoking |
27 (10.4) |
Alcoholism |
0 (0) |
Therapeutic failure risk factors, n (%) |
|
Age > 65 years |
63 (24.2) |
Cancer |
16 (6.2) |
Anemia |
16 (6.2) |
Liver cirrhosis |
1 (0.4) |
Renal failure |
1 (0.4) |
Acute liver failure |
0 (0) |
End stage renal failure |
2 (0.8) |
Coagulopathy |
2 (0.8) |
Immunosuppression |
2 (0.8) |
Leukopenia |
0 (0) |
Primary surgical intervention site, n (%) |
|
Appendix |
162 (62.3) |
Lower GI tract |
51 (19.6) |
Upper GI tract |
13 (5.0) |
Gall-bladder |
14 (5.4) |
Peritoneal abscess |
16 (6.1) |
Explorative laparotomy/laparoscopy |
4 (1.5) |
Surgical approach, n (%) |
|
Laparoscopy |
135 (51.9) |
Laparotomy |
116 (44.6) |
Percutaneous |
9 (3.5) |
Illness severity markers, n (%) |
|
Parenteral nutrition |
52 (20.0) |
Central venous catheter |
44 (16.9) |
Antifungal drugs |
28 (10.8) |
Enteral nutrition |
22 (8.4) |
Invasive mechanical ventilation |
20 (7.7) |
Immune globulins |
0 (0) |
Renal replacement therapies |
0 (0) |
ICU transfer, n (%) |
24 (9.2) |
Mean ± SD length of hospital stay, days |
10.4 ± 13 |
Mortality rate, n (%) | 6 (2.3) |
GI, gastrointestinal; ICU, intensive care unit; SD, standard deviation.